Characteristic | Pre-intervention phase N = 606 (%) | Intervention phase N = 405 (%) | Total 1,011 (%) |
---|---|---|---|
Age (years) | |||
 18–24 | 79 (13.0) | 60 (14.8) | 139 (13.8) |
 25–34 | 292 (48.2) | 201 (49.6) | 493 (48.8) |
 35–44 | 169 (27.9) | 112 (27.7) | 281 (27.8) |
 > 44 | 45 (7.4) | 32 (7.9) | 77 (7.6) |
 Missing data | 21 (3.5) | 0 (0.0) | 21 (2.1) |
Sex | |||
 Female | 326 (53.8) | 202 (49.9) | 528 (52.2) |
 Male | 280 (46.2) | 202 (49.9) | 482 (47.7) |
 Missing data | 0 (0) | 1 (0.3) | 1 (0.1) |
WHO stage | |||
 I | 397 (65.5) | 271 (66.9) | 668 (66.1) |
 II | 164 (27.1) | 77 (19.0) | 241 (23.8) |
 III | 42 (6.9) | 6 (1.5) | 48 (4.7) |
 IV | 1 (0.2) | 2 (0.5) | 3 (0.3) |
 Missing Data | 2 (0.3) | 49 (12.0) | 51 (5.0) |
Entry point | |||
 Facility outreach | 150 (24.8) | 345 (85.2) | 495 (49.0) |
 Main facility | 401 (66.2) | 60 (14.8) | 461 (45.6) |
 Missing data | 55 (9.1) | 0 (0.0) | 55 (5.4) |